← Back to Search

Itch CBT for Atopic Dermatitis

N/A

Waitlist Available

Led By Amy Paller, MD

Research Sponsored by Northwestern University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to week 4

Awards & highlights

No Placebo-Only Group

Summary

This trial tests a special type of talk therapy to help children with eczema manage their itching. The therapy teaches kids to change how they think about their itch and find better ways to cope with it. This approach aims to improve their quality of life without using medication.

Eligible Conditions

Atopic Dermatitis

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to week 4

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to week 4

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to week 4 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Itch Severity Numerical Rating Scale

Secondary study objectives

Itch Rumination Questionnaire

PROMIS Anxiety and Depression

PROMIS Pediatric Itch - Short Form 1 (2+6)

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Itch CBT ArmExperimental Treatment1 Intervention

Participants randomized to the Itch CBT Arm will participate in 4 weekly telehealth sessions with a therapist to address common areas of anxiety related to atopic dermatitis.

Group II: Usual Care ArmActive Control1 Intervention

Participants randomized to the Usual Care Arm of the study will receive standard of care eczema educational materials that are typically provided by their health care provider after a clinic (or telehealth) visit.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Itch CBT

2020

N/A

~20

Do I qualify?Apply below to find out